PARADIGM study (PAnitumumab and RAS, DIagnostically-useful Gene Mutation for mCRC)
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2614086
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Randomization
Primary outcome(s): The following item concerning all sites and a primary tumor occupying a left-sided site* (hereinafter referred to as left-side)
Overall survival (OS)
*:Primary tumors occupying a left-sided site include the descending colon, sigmoid colon, and rectum.
Study Design: randomized controlled trial, open(masking not used), active control, parallel assignment, treatment purpose
创建时间：
2015-05-15
